Reports - Opioids Market
HealthcareOpioids Market
Opioids Market Size and Projected Growth Through 2035 by Product (Codeine, Fentanyl, Methadone, Oxycodone, Morphine, Hydrocodone, Others) by Application (Pain Management, Cough Treatment, Diarrhea, De-addiction) by Route of administration (oral, Injectable, Others) by Distribution channel (Hospital pharmacy, Retail pharmacy, Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Opioids Market - Segment Analysis
1. Overview
2. Global Opioids Market, 2021 - 2035 (USD Million)
3. Global Opioids Market - by Product
3.1. By Codeine
3.2. By Fentanyl
3.3. By Methadone
3.4. By Oxycodone
3.5. By Morphine
3.6. By Hydrocodone
3.7. By Others
4. Global Opioids Market - by Application
4.1. By Pain Management
4.2. By Cough Treatment
4.3. By Diarrhea
4.4. By De-addiction
5. Global Opioids Market - by Route of administration
5.1. By oral
5.2. By Injectable
5.3. By Others
6. Global Opioids Market - by Distribution channel
6.1. By Hospital pharmacy
6.2. By Retail pharmacy
6.3. By Others
7. Global Opioids Market - by region
7.1. North America
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Market comparative analysis
Chapter 4 North America Opioids Market - Segment Analysis
1. Overview
2. North America Opioids Market, 2021 - 2035 (USD Million)
3. North America Opioids Market - by Product
3.1. By Codeine
3.2. By Fentanyl
3.3. By Methadone
3.4. By Oxycodone
3.5. By Morphine
3.6. By Hydrocodone
3.7. By Others
4. North America Opioids Market - by Application
4.1. By Pain Management
4.2. By Cough Treatment
4.3. By Diarrhea
4.4. By De-addiction
5. North America Opioids Market - by Route of administration
5.1. By oral
5.2. By Injectable
5.3. By Others
6. North America Opioids Market - by Distribution channel
6.1. By Hospital pharmacy
6.2. By Retail pharmacy
6.3. By Others
Chapter 5 Europe Opioids Market - Segment Analysis
1. Overview
2. Europe Opioids Market, 2021 - 2035 (USD Million)
3. Europe Opioids Market - by Product
3.1. By Codeine
3.2. By Fentanyl
3.3. By Methadone
3.4. By Oxycodone
3.5. By Morphine
3.6. By Hydrocodone
3.7. By Others
4. Europe Opioids Market - by Application
4.1. By Pain Management
4.2. By Cough Treatment
4.3. By Diarrhea
4.4. By De-addiction
5. Europe Opioids Market - by Route of administration
5.1. By oral
5.2. By Injectable
5.3. By Others
6. Europe Opioids Market - by Distribution channel
6.1. By Hospital pharmacy
6.2. By Retail pharmacy
6.3. By Others
Chapter 6 Asia Pacific Opioids Market - Segment Analysis
1. Overview
2. Asia Pacific Opioids Market, 2021 - 2035 (USD Million)
3. Asia Pacific Opioids Market - by Product
3.1. By Codeine
3.2. By Fentanyl
3.3. By Methadone
3.4. By Oxycodone
3.5. By Morphine
3.6. By Hydrocodone
3.7. By Others
4. Asia Pacific Opioids Market - by Application
4.1. By Pain Management
4.2. By Cough Treatment
4.3. By Diarrhea
4.4. By De-addiction
5. Asia Pacific Opioids Market - by Route of administration
5.1. By oral
5.2. By Injectable
5.3. By Others
6. Asia Pacific Opioids Market - by Distribution channel
6.1. By Hospital pharmacy
6.2. By Retail pharmacy
6.3. By Others
Chapter 7 Latin America Opioids Market - Segment Analysis
1. Overview
2. Latin America Opioids Market, 2021 - 2035 (USD Million)
3. Latin America Opioids Market - by Product
3.1. By Codeine
3.2. By Fentanyl
3.3. By Methadone
3.4. By Oxycodone
3.5. By Morphine
3.6. By Hydrocodone
3.7. By Others
4. Latin America Opioids Market - by Application
4.1. By Pain Management
4.2. By Cough Treatment
4.3. By Diarrhea
4.4. By De-addiction
5. Latin America Opioids Market - by Route of administration
5.1. By oral
5.2. By Injectable
5.3. By Others
6. Latin America Opioids Market - by Distribution channel
6.1. By Hospital pharmacy
6.2. By Retail pharmacy
6.3. By Others
Chapter 8 Middle East & Africa Opioids Market - Segment Analysis
1. Overview
2. Middle East & Africa Opioids Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Opioids Market - by Product
3.1. By Codeine
3.2. By Fentanyl
3.3. By Methadone
3.4. By Oxycodone
3.5. By Morphine
3.6. By Hydrocodone
3.7. By Others
4. Middle East & Africa Opioids Market - by Application
4.1. By Pain Management
4.2. By Cough Treatment
4.3. By Diarrhea
4.4. By De-addiction
5. Middle East & Africa Opioids Market - by Route of administration
5.1. By oral
5.2. By Injectable
5.3. By Others
6. Middle East & Africa Opioids Market - by Distribution channel
6.1. By Hospital pharmacy
6.2. By Retail pharmacy
6.3. By Others
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. AbbVie
2. Allergan
3. Orexo Pharmaceuticals
4. Sanofi
5. Teva Pharmaceuticals
6. Pfizer
7. Hospira
8. Endo Pharmaceuticals
9. Purdue Pharma
10. Sun Pharmaceutical Industries Limited
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By